Belmont, MA, United States of America

Gerald Carson


Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2011-2016

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Gerald Carson: Innovator in Biologic Production

Introduction

Gerald Carson is a notable inventor based in Belmont, MA (US), recognized for his contributions to the field of biologic production. With a total of 3 patents, he has made significant advancements in methods that enhance the efficiency of cell line development processes.

Latest Patents

One of his latest patents is titled "Methods of selecting biologic-producing cell lines by next generation sequencing." This patent discloses an optimized multi-step cell line screening method that utilizes next generation sequencing (NGS) and mass spectrometry (MS). The method aims to reduce variants in biologic-producing cell lines, thereby improving the overall efficiency of the cell line development process. Another significant patent is "Recombinant expression vector elements (REVES) for enhancing expression of recombinant proteins in host cells." This patent describes compositions and methods that comprise recombinant expression vector elements (rEVEs) to enhance the expression levels of recombinant proteins. Additionally, it includes methods for lowering or substantially suppressing the expression of recombinant proteins.

Career Highlights

Throughout his career, Gerald Carson has worked with prominent companies such as AbbVie Inc. and Abbott Laboratories Corporation. His experience in these organizations has contributed to his expertise in biologic production and recombinant protein expression.

Collaborations

Gerald has collaborated with notable coworkers, including Wendy R. Gion and Hong Gao, who have also made significant contributions in their respective fields.

Conclusion

Gerald Carson's innovative work in biologic production and recombinant protein expression has established him as a key figure in the industry. His patents reflect a commitment to improving methodologies that enhance the efficiency of cell line development processes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…